Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label StudyFrancesco Di Pierro, Sagheer Ahmed, Giuseppe Derosa et al.|International Journal of General Medicine|2021Cited by 183
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialFrancesco Di Pierro, Saeed Khan, Pamela Maffioli et al.|International Journal of General Medicine|2021Cited by 177